Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients
Journal of Clinical Immunology · 2025
DOI: 10.1007/s10875-025-01934-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Immunology, 2025. Verfasst von Ismail Yaz und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Department of Pediatric Basic Sciences, Institute of Child Health, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Genetic Diseases, X-Linked, Diarrhea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked(IPEX) syndrome caused by FOXP3 mutations is rare. FOXP3 is a transcription factor required for the regulatory T cell (Treg) development/function. AIM: We aimed to characterize the clinical, immunologic, and genetic features of a single-center cohort of IPEX syndrome. PATIENTS AND METHODS: We present the clinical/immunological/genetic features of 12 patients with IPEX syndrome. We used whole exome and Sanger sequencing for the diagnosis/familial segregation. We performed immunophenotyping and measured Treg percentage and FOXP3 expression in peripheral blood by flow cytometric analysis. RESULTS: Median age at diagnosis was 2.5 years (range: 0.3-22 years). Common clinical manifestations were infections (n = 9, 75%), allergies (n = 8, 67%), autoimmunity (n = 7, 58%), enteropathy (n = 7, 58%), and lymphoproliferation (n = 3, 25%). Atypical initial presentations included class IV lupus nephritis, a SCID-like immunophenotype (CD3+ T cells: 4% [100/µL]; CD4+ T cells: 3%, CD8+ T cells: 1%, CD19+ B cells: 81%, CD16/56+ NK cells: 13%), and isolated hypogammaglobulinemia persisting for years during follow-up. At the time of diagnosis, three (25%) patients had leukopenia, six (50%) had lymphopenia and two (17%) had neutropenia. Eosinophilia was observed in 42% of patients (25% mild, 17% moderate). Six different variants in FOXP3 were characterized in 12 patients from nine unrelated families. Four (33%) patients underwent hematopoietic stem cell transplantation (HSCT). Overall, three (25%) patients died due to infections. One patient died due to HSCT-related catheter complications, one patient died in an accident. Among the transplanted patients, two are alive and well. Among the non-transplanted patients, five are alive and are being followed up at our center. Treg (CD4+CD127-/lowCD25+Foxp3+) percentage was low in eight patients compared to healthy controls (p < 0.001). FOXP3 expression was low in all the patients compared to healthy controls. CONCLUSION: Atypical presentations make the diagnosis of IPEX syndrome challenging. This study expands the current knowledge of IPEX syndrome by describing a single-center cohort with certain atypical manifestations and by confirming previously reported rare phenotypes. Elucidating the genetic basis of immunodeficiency diseases contributes to improving diagnostic approaches and patient management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Immunology, Department of Pediatric Basic Sciences, Institute of Child Health, Hacettepe University, Ankara, Turkey.
- Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey.
- Division of Immunology, Department of Pediatrics, Hacettepe University Medical School, Ankara, Turkey.
- Division of Allergy, Department of Pediatrics, Hacettepe University Medical School, Ankara, Turkey.
- Department of Biostatistics, Hacettepe University Medical School, Ankara, Turkey.
- Division of Hematology, Department of Pediatrics, Hacettepe University Medical School, Ankara, Turkey.
Zitieren
APA
Yaz, I., Oskay Halacli, S., Ipsir, C., Ulum, B., Soyak Aytekin, E., Bildik, H. N., Ocak, M., Avci, H., Okur, F. V., Hizarcioglu Gulsen, H., Demir, H., Metin, A., Ozon, A., Kuskonmaz, B., Tezcan, I., Esenboga, S., & Cagdas, D. (2025). Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-025-01934-7
Vancouver
Yaz I, Oskay Halacli S, Ipsir C, Ulum B, Soyak Aytekin E, Bildik HN, et al. Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients. Journal of Clinical Immunology. 2025. doi:10.1007/s10875-025-01934-7
BibTeX
@article{Yaz2025,
author = {Yaz, Ismail and Oskay Halacli, Sevil and Ipsir, Canberk and Ulum, Baris and Soyak Aytekin, Elif and Bildik, Hacer Neslihan and Ocak, Melike and Avci, Hanife and Okur, Fatma Visal and Hizarcioglu Gulsen, Hayriye and Demir, Hulya and Metin, Ayse and Ozon, Alev and Kuskonmaz, Baris and Tezcan, Ilhan and Esenboga, Saliha and Cagdas, Deniz},
title = {Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients},
journal = {Journal of Clinical Immunology},
year = {2025},
doi = {10.1007/s10875-025-01934-7}
}
EUVIMED